Ai In Action

Today's guest is Naisha Shah, VP of Data Science at BioAge Labs in California. Founded in 2015, BioAge are on a mission to develop a pipeline of treatments that extend healthy lifespan by targeting the molecular causes of aging. BioAge takes a human-centric, data-driven approach to identify the molecular features of healthy aging and reveal the causes of age-related diseases. By targeting aging with a large and mechanistically diverse portfolio of drugs, they will unlock opportunities to treat or even prevent these diseases in entirely new ways. Naisha leads a team of data scientists at BioAge that are developing statistical, Machine Learning and AI pipelines to identify targets for new therapeutics to increase healthspan. The team leverages proprietary human cohorts with longitudinal omics and phenotypic data for data-driven insights into mechanisms of aging and age-related diseases. Naisha brings 10+ years of experience in computational analysis of multi-omics, clinical, imaging, EHR, and other phenotyp